Comparative Experimental Study Between Bupivacaine and Ropivacaine Regarding Efficacy in Third Molar Removal Surgery Under General Anesthesia

NCT07108465 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Third Molars Extraction

Interventions

DRUG: Bupivacaine 0,5%
DRUG: Ropivacaine 0,75%

Sponsor

Henrique Tedesco